Ronald Hans Wilmar Lorijn
Chief Executive Officer at NeuExCell Therapeutics, Inc.
Profile
Ronald Hans Wilmar Lorijn currently works at NeuExCell Therapeutics, Inc., as Chief Executive Officer and nLife Therapeutics SL, as Director.
Dr. Lorijn also formerly worked at Amsterdam Molecular Therapeutics (AMT) Holding NV, as Chief Executive Officer, uniQure NV, as Chief Executive Officer, Esperite NV, as Non Executive Director in 2010, Centocor, Inc., as Chief Medical Officer, Pepscan Therapeutics BV, as Member-Supervisory Board from 2012 to 2016, and Janssen Biologics BV, as Chief Medical Officer.
Dr. Lorijn received his doctorate degree from Radboud University Nijmegen.
Ronald Hans Wilmar Lorijn active positions
| Companies | Position | Start |
|---|---|---|
nLife Therapeutics SL
 nLife Therapeutics SL Pharmaceuticals: MajorHealth Technology nLife Therapeutics SL develops and manufactures pharmaceutical preparations. It specializes in oligonucleotides as therapeutic agents for central nervous system and neuromuscular disorders. The company was founded by Andres Pablo Montefeltro on September 24, 2009 and is headquartered in Armilla, Spain. | Director/Board Member | - |
NeuExCell Therapeutics, Inc.
 NeuExCell Therapeutics, Inc. Medical/Nursing ServicesHealth Services NeuExCell Therapeutics, Inc. operates as a biotechnology company. The company is headquartered in State College, PA. | Chief Executive Officer | - |
Former positions of Ronald Hans Wilmar Lorijn
| Companies | Position | End |
|---|---|---|
Pepscan Therapeutics BV
 Pepscan Therapeutics BV Pharmaceuticals: MajorHealth Technology Pepscan Therapeutics BV develops immunotherapeutic products in oncology. The company was founded in 2000 and is headquartered in Lelystad, the Netherlands. | Director/Board Member | - |
Amsterdam Molecular Therapeutics (AMT) Holding NV
 Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands. | Chief Executive Officer | 2009-01-31 |
| UNIQURE N.V. | Chief Executive Officer | 2009-01-31 |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Chief Tech/Sci/R&D Officer | - |
Janssen Biologics BV
 Janssen Biologics BV Pharmaceuticals: MajorHealth Technology Janssen Biologics BV manufactures, acquires and markets biopharmaceutical therapies. The firms products focus on cardiovascular and immunological disorders, and cancer. The company was founded in 1984 and is headquartered in Leiden, the Netherlands. | Chief Tech/Sci/R&D Officer | - |
Training of Ronald Hans Wilmar Lorijn
| Radboud University Nijmegen | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| UNIQURE N.V. | Health Technology |
| Private companies | 7 |
|---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Health Technology |
Esperite NV
 Esperite NV Medical/Nursing ServicesHealth Services Esperite NV was a diversified biotech global group. The firm specialized in Immunotherapy, Regenerative Medicine, and Precision Medicine. The company was founded by Johan Paul Georges Goossens and Marc Jan Waeterschoot on March 8, 2000 and was headquartered in Zutphen, the Netherlands. | Health Services |
Amsterdam Molecular Therapeutics (AMT) Holding NV
Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands. | Commercial Services |
Pepscan Therapeutics BV
Pepscan Therapeutics BV Pharmaceuticals: MajorHealth Technology Pepscan Therapeutics BV develops immunotherapeutic products in oncology. The company was founded in 2000 and is headquartered in Lelystad, the Netherlands. | Health Technology |
Janssen Biologics BV
Janssen Biologics BV Pharmaceuticals: MajorHealth Technology Janssen Biologics BV manufactures, acquires and markets biopharmaceutical therapies. The firms products focus on cardiovascular and immunological disorders, and cancer. The company was founded in 1984 and is headquartered in Leiden, the Netherlands. | Health Technology |
nLife Therapeutics SL
nLife Therapeutics SL Pharmaceuticals: MajorHealth Technology nLife Therapeutics SL develops and manufactures pharmaceutical preparations. It specializes in oligonucleotides as therapeutic agents for central nervous system and neuromuscular disorders. The company was founded by Andres Pablo Montefeltro on September 24, 2009 and is headquartered in Armilla, Spain. | Health Technology |
NeuExCell Therapeutics, Inc.
NeuExCell Therapeutics, Inc. Medical/Nursing ServicesHealth Services NeuExCell Therapeutics, Inc. operates as a biotechnology company. The company is headquartered in State College, PA. | Health Services |
- Stock Market
- Insiders
- Ronald Hans Wilmar Lorijn
